Underwriters Laboratories (UL), a leader in product safety testing and certification services for more than 116 years, and Earth Day Network (EDN), the international non-profit environmental organization that coordinates Earth Day programs have announced a joint effort to help keep families safe and their environment healthy. As the premiere sponsor of EDN's upcoming 40th Anniversary celebration of Earth Day, UL has become the
More than 15,000 injuries involving holiday decorating resulted in emergency room visits in 2012, according to the U.S. Consumer Product Safety Commission. The National Fire Protection Association (NFPA) reports that U.S. fire departments respond to an average of 230 home fires each season involving Christmas trees.
In light of these statistics, UL, a global safety science leader, is sharing tips about tree safety, decorating safety and home entertaining safety during the holiday season, including ways that consumers can safeguard their homes and loved ones.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7394851-ul-safe-holiday-celebration-home-tips/
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the company’s state-of-the-art research center in Billerica, MA, is LEED® Gold certified under the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED® is the nation’s preeminent program for the design, construction and operation of high performance green buildings. The Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and fertility, and is one of only five laboratories in Massachusetts to achieve this high rating.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/emdserono/49715/
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced plans to launch its new epilepsy-focused educational website, www.Epilog.us, at the American Epilepsy Society (AES) annual meeting, December 3-5, 2011. The new website will be featured at the Upsher-Smith booth (# 102) and marks an important landmark in the Company’s commitment to the epilepsy community.
To view Multimedia News Release go to http://www.multivu.com/mnr/53440-upsher-smith-launches-new-epilepsy-focused-website
http://www.ftrintl.com/ FTR International Inc. is a an award-winning and highly innovative Union general contracting, engineering, and construction management firm that has successively proven its exceptional ethic in the successful delivery of over 100 multi-million dollar projects since our initiation in 1984. With offices in Irvine and Los Angeles, California, FTR prides itself with a diverse public works and private project portfolio, totaling billions of dollars' worth of construction costs in General Contracting, Design/Build and Construction Management delivery. Our diverse project portfolio includes state-of-the-art science laboratories, health centers, educational institutions, aviation terminals, art and theater facilities, ultra-modern mass transit stations, port security services, complex water reclamations, environmental sewage treatment facilities, and electrical power distribution centers and our industry reach extends to more than sixty public agencies.
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, http://www.Epilog.us, has been expanded to include thought-leader commentary on issues related to Epilepsy and Comorbidities. The newly updated website will make its debut at the 64th Annual American Academy of Neurology Meeting in New Orleans on April 23 – 26, 2012, at the Upsher-Smith exhibit, booth number 128.
TO view Multimedia News Release, go to http://www.multivu.com/mnr/55934-upsher-smith-expands-epilog-us-on-epilepsy-comorbidities
Upsher-Smith Laboratories, Inc. today announced the nationwide launch of Provella™, a unique probiotic dietary supplement specifically designed for women to promote digestive, feminine, and immune health.* Provella™ helps restore and maintain balance of good bacteria to support digestive and vaginal health.* Taken once-daily by mouth, Provella™ tablets contain a proprietary blend of six bacteria strains that include: Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, and Bifidobacterium bifidum.
Provella™ is available without a prescription behind the pharmacy counter at retail pharmacies nationwide and online at www.drugstore.com. Consumers can also ask any local pharmacist to order Provella™ using List Number 0245-1060-30.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56871-upsher-smith-provella-probiotic-supports-digestive-feminine-immune-health
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Rough, dry skin may seem like a constant battle for some, especially as cold weather creeps in. When it comes to defeating dryness, leading New York Cosmetic Dermatologist, Dr. Doris Day, recommends following three cardinal rules: cleanse, exfoliate and moisturize. Using a mild cleanser helps rid skin of daily dirt buildup without stripping it of its essential oils. Once skin is clean and dry, applying a moisturizer with 12% lactic acid, like AmLactin® Moisturizing Body Lotion, aids in skin’s natural renewal process, exfoliating dead skin cells while simultaneously locking in moisture to the new cells underneath.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59155-upsher-smith-laboratories-amlactin-moisturizing-body-lotion
Approximately 1.5 million women and girls in the United States have epilepsy, of which nearly 500,000 are women of childbearing age. Treating women with epilepsy, especially women of childbearing age, presents significant challenges to physicians. Epilog.us [http://www.epilog.us], Upsher-Smith Laboratories, Inc’s [http://www.upsher-smith.com] epilepsy-focused educational website, discusses these challenges and provides professional insight by some of the epilepsy community’s most respected physicians including Dr. Cynthia Harden, Chief of the Comprehensive Epilepsy Care Center, North Shore University Hospital and Long Island Jewish Medical Center, and Dr. Christopher Skidmore, Director of Neurology Residency/Assistant Professor of Neurology, at Jefferson Medical College of Thomas Jefferson University.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59306-upsher-smith-epilog-website-challenges-in-managing-women-with-epilepsy
Upsher-Smith Laboratories, Inc., today announced the addition of the topic Sleep Disorders and Epilepsy to its epilepsy-focused educational website, Epilog.us. The site now features a review of the relationship between epilepsy and sleep disorders.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59872-epilog-us-expert-discussion-comorbidity-of-sleep-disorders-and-seizures
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced its next-generation mobile strategy for the laboratory―to provide a flexible and secure mobile computing environment that effectively connects scientists, equipment and materials in today’s laboratories where an increasing number and variety of mobile devices, from smart phones to tablet computers, are in use. With over a decade of experience in pioneering paperless, mobile computing and wireless compliance capabilities in regulated laboratories, Accelrys will empower organizations to deploy purpose-built mobile applications in the lab from research to manufacturing, satisfying specific workflow requirements in accordance with Good Manufacturing Practice.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65931-accelrys-capture-drives-next-generation-mobility-in-the-laboratory
BloodCenter of Wisconsin’s Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7363151-bloodcenter-of-wisconsin-launches-next-generation-sequencing-hemeonc-panel/
